Leelyn Smith’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-200
Closed -$2.2K 311
2022
Q4
$2.2K Buy
+200
New +$2.2K ﹤0.01% 406